Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 444

Similar articles for PubMed (Select 18948197)

1.

Immune evasion in Kaposi's sarcoma-associated herpes virus associated oncogenesis.

Liang C, Lee JS, Jung JU.

Semin Cancer Biol. 2008 Dec;18(6):423-36. doi: 10.1016/j.semcancer.2008.09.003. Epub 2008 Oct 2. Review.

PMID:
18948197
2.

Immune evasion strategies of Kaposi's sarcoma-associated herpesvirus.

Means RE, Choi JK, Nakamura H, Chung YH, Ishido S, Jung JU.

Curr Top Microbiol Immunol. 2002;269:187-201. Review.

PMID:
12224509
3.

Immune evasion by Kaposi's sarcoma-associated herpesvirus.

Coscoy L.

Nat Rev Immunol. 2007 May;7(5):391-401. Review.

PMID:
17457345
4.

Characterization of the human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) oncogene, kaposin (ORF K12).

Muralidhar S, Veytsmann G, Chandran B, Ablashi D, Doniger J, Rosenthal LJ.

J Clin Virol. 2000 May;16(3):203-13.

PMID:
10738139
5.

Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis.

Viejo-Borbolla A, Schulz TF.

AIDS Rev. 2003 Oct-Dec;5(4):222-9. Review.

PMID:
15012001
6.

The pleiotropic effects of Kaposi's sarcoma herpesvirus.

Schulz TF.

J Pathol. 2006 Jan;208(2):187-98. Review.

PMID:
16362980
7.

Immune evasion by Kaposi's sarcoma-associated herpesvirus.

Lee HR, Lee S, Chaudhary PM, Gill P, Jung JU.

Future Microbiol. 2010 Sep;5(9):1349-65. doi: 10.2217/fmb.10.105. Review.

8.

Linking KSHV to human cancer.

Wong EL, Damania B.

Curr Oncol Rep. 2005 Sep;7(5):349-56. Review.

PMID:
16091195
9.

HIV-1 infection of primary effusion lymphoma cell line triggers Kaposi's sarcoma-associated herpesvirus (KSHV) reactivation.

Merat R, Amara A, Lebbe C, de The H, Morel P, Saib A.

Int J Cancer. 2002 Feb 20;97(6):791-5.

PMID:
11857356
10.

Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.

Bihl F, Mosam A, Henry LN, Chisholm JV 3rd, Dollard S, Gumbi P, Cassol E, Page T, Mueller N, Kiepiela P, Martin JN, Coovadia HM, Scadden DT, Brander C.

AIDS. 2007 Jun 19;21(10):1245-52.

PMID:
17545700
11.

Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.

Abe Y, Matsubara D, Gatanaga H, Oka S, Kimura S, Sasao Y, Saitoh K, Fujii T, Sato Y, Sata T, Katano H.

Pathol Int. 2006 Oct;56(10):617-24.

PMID:
16984619
12.
13.

The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases.

Cesarman E.

Recent Results Cancer Res. 2002;159:27-37. Review.

PMID:
11785841
14.

Kaposi's sarcoma-associated herpesvirus: clinical, diagnostic, and epidemiological aspects.

Cohen A, Wolf DG, Guttman-Yassky E, Sarid R.

Crit Rev Clin Lab Sci. 2005;42(2):101-53. Review.

PMID:
15941082
15.
16.

Kaposi's sarcoma-associated herpesvirus immune modulation: an overview.

Rezaee SA, Cunningham C, Davison AJ, Blackbourn DJ.

J Gen Virol. 2006 Jul;87(Pt 7):1781-804. Review.

18.

Linking the Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to human malignancies.

Kalt I, Masa SR, Sarid R.

Methods Mol Biol. 2009;471:387-407. doi: 10.1007/978-1-59745-416-2_19.

PMID:
19109790
19.

Molecular piracy of Kaposi's sarcoma associated herpesvirus.

Choi J, Means RE, Damania B, Jung JU.

Cytokine Growth Factor Rev. 2001 Jun-Sep;12(2-3):245-57. Review.

PMID:
11325605
20.

Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with human myeloid cell nuclear differentiation antigen induced by interferon alpha.

Fukushi M, Higuchi M, Oie M, Tetsuka T, Kasolo F, Ichiyama K, Yamamoto N, Katano H, Sata T, Fujii M.

Virus Genes. 2003 Dec;27(3):237-47.

PMID:
14618084
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk